Delivery Order SPE2DB24D2217-SPE2DB25FJXDU

Award Date 6/23/25
Potential Completion Date 6/24/25
Potential Value $3.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the medication WEGOVY 0.5 mg/0.5 ml pen. The delivery order has a ceiling value of $1,638.00 and a period of performance through May 1, 2025. The contract is a firm fixed-price, non-set-aside award. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order is for the medication WEGOVY 0.25 MG/0.5 ML PEN 0.5ML, with a ceiling value of $9,977.75 and a period of performance through May 23, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the prescription medication WEGOVY 0.5 MG/0.5 ML PEN 0.5ML. The contract has a firm fixed price of $2,415.52 and a completion date of April 15, 2025. It is not a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of the medication WEGOVY 0.25 MG/0.5 ML PEN 0.5ML. The contract has a ceiling value of $1,363.18 and a period of performance through May 5, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside designation, indicating open competition. This delivery order is part of a larger Indefinite Delivery...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the medication WEGOVY 0.25 MG/0.5 ML PEN 0.5ML, with a ceiling value of $4,914.00 and a period of performance through May 1, 2025. The contract is a firm fixed price, non-set-aside delivery order. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the pharmaceutical product WEGOVY 1 MG/0.5 ML PEN 0.5ML, with a ceiling value of $2,379.26 and a period of performance through June 18, 2025. The contract is a Firm Fixed Price delivery order, with no set-aside designation. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of the medication WEGOVY 1.7 MG/0.75 ML PEN 0.75ML. The contract has a firm fixed-price, non-set-aside pricing structure and a ceiling value of $13,179.60. The period of performance extends through May 12, 2025. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $88,605.67, is for the delivery of the prescription medication WEGOVY 0.25 MG/0.5 ML PEN 0.5ML. The contract has a firm fixed price and an ultimate completion date of December 23, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,156.97 contract is for the supply of the medication WEGOVY 1.7 MG/0.75 ML PEN 0.75ML, with a period of performance through February 4, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,228.50, is for the delivery of the drug WEGOVY 2.4 MG/0.75 ML PEN 0.75ML. The contract has a firm fixed price pricing type and a period of performance ending on March 19, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
  • SPE2DB24D2217
    Indefinite Delivery Contract
  • SPE2DB24D2217-SPE2DB25FJXDU
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order is for the medication WEGOVY 0.25 MG/0.5 ML PEN 0.5ML, with a firm fixed price ceiling value of $3,745.15 and a period of performance through June 24, 2025. The contract is not set aside and represents open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.

Generated 9/22/25, 9:52 AM